Apollo Management Holdings, L.P. Eton Pharmaceuticals, Inc. Transaction History

Apollo Management Holdings, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$7.1 - $8.39 $639,000 - $755,100	-90,000 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$5.79 - $6.68 $521,100 - $601,200	90,000 New	90,000 $551,000

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $264M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Apollo Management Holdings, L.P., based on Form 13F filings with the SEC.

Stay updated on Apollo Management Holdings, L.P. with notifications on news.